VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older
Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda
A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant
The Interaction Between Measles and DTP Vaccination
† Study has passed its completion date and status has not been verified in more than two years.